Coherus Oncology, Inc.
CHRS
A reverse discounted cash flow for Coherus Oncology, Inc. starts from what it has actually filed: the 2025 revenue and margin on this company's own statements. It asks what growth the current price is already assuming. That needs a live price, which is the one figure on this site that costs money to fetch, so it runs on an account rather than on a page anybody can open.
Valuation
Seeded from CHRS’s own filed revenue, margin and trading multiples, against a live price. An account is what lets this run, for the reason above.
Sign in to run it on Coherus Oncology, Inc.Run the numbers on Coherus Oncology, Inc. yourself.
Ten seconds, no card, and nothing to cancel.
What an account lets you do with Coherus Oncology, Inc.
Ask what growth the price is already betting on
A reverse DCF on CHRS's filed revenue and margin, run against the price right now, not a guess about the future.
See every filed year, not just the recent ones
The statements this company has actually filed, in the way it filed them.
Every year on recordMeasure
Ask about any of it, get the filing back
The assistant answers from this company's own statements, and links every figure straight to its source.
Free, no card, and it does not expire.